OrganiGram (CVE:OGI) had its price target cut by equities researchers at Canaccord Genuity from C$8.50 to C$7.00 in a report issued on Wednesday, BayStreet.CA reports.
Several other analysts also recently weighed in on the stock. AltaCorp Capital lowered their target price on shares of OrganiGram from C$13.15 to C$6.50 in a report on Tuesday. CIBC set a C$9.00 target price on shares of OrganiGram and gave the company an “outperform” rating in a report on Tuesday, September 24th. Finally, Jefferies Financial Group raised shares of OrganiGram from a “hold” rating to a “buy” rating and lowered their target price for the company from C$10.50 to C$8.20 in a report on Friday, October 11th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. OrganiGram has a consensus rating of “Buy” and a consensus target price of C$8.60.
The stock has a market capitalization of $661.23 million and a P/E ratio of 28.02. The company has a fifty day moving average price of C$6.22 and a 200-day moving average price of C$7.97. The company has a current ratio of 9.06, a quick ratio of 4.14 and a debt-to-equity ratio of 14.71. OrganiGram has a fifty-two week low of C$4.11 and a fifty-two week high of C$11.30.
OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.
Featured Article: What are the benefits of a balanced fund?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.